Glyceryl Ricinoleate is the monoester of glycerol and ricinoleic acid. Castor oil contains 87–90% Glycerol Ricinoleate. Ricinoleic acid is metabolized by both β-oxidation and α-oxidation.
Acute oral toxicity tests in mice indicated that Glyceryl Ricinoleate has an LD50 greater than 25.0 ml/kg and is, at most, mildly irritating to unrinsed rabbit eyes. This ingredient was not a primary skin irritant.
Castor oil was nonmutagenic by the Ames test. Ricinoleic acid was not a carcinogen when tested in mice.
In human single-insult occlusive patch tests, no indication of skin irritation potential was observed in the two products containing 5.6% Glyceryl Ricinoleate.
The available data on Glyceryl Ricinoleate were insufficient to determine whether this ingredient, under each relevant condition of use, was either safe or not safe. The types of data required before a decision can be made include: (1) 28 day chronic dermal toxicity in guinea pigs, and (2) clinical sensitization and photosensitization studies (or an appropriate ultraviolet spectrum instead of the photosensitization data).
References
1.
1. Estrin, N.F., Crosley, P.A., and Haynes, C.R. (eds.). (1982). Cosmetic, Toiletry and Fragrance Association Cosmetic Ingredient Dictionary, 3rd ed.Washington, D.C.: The Cosmetic, Toiletry and Fragrance Association.
2.
2. Estrin, N.F., Haynes, C.R., and Whelan, J.M. (eds.). (1982). CTFA Compendium of Cosmetic Ingredient Compositions. Cosmetic Ingredient Descriptions. Washington, D.C.: The Cosmetic, Toiletry and Fragrance Association.
3.
3. Weast, R.C. (1984). CRC Handbook of Chemistry and Physics, 65th ed., 1984–1985. Boca Raton, FL: CRC press, p. C-314.
4.
4. Greenberg, L.A., and Lester, D. (1954). Handbook of Cosmetic Materials. New York: Interscience.
5.
5. Grayson, M. (1984). Kirk-Othmer Encyclopedia of Chemical Technology, Vol. 11. New York: John Wiley and Sons, p. 931.
7. Paulus, G.L. and Champion, M.H. (1972). Gas-liquid chromatographic determination of castor oil as methyl ricinoleate in lipstick. J. Soc. Cosmet. Chem.23, 313–9.
8.
8. Binder, R.G., Applewhite, T.H., Kohler, G.O., and Goldblatt, L.A. (1962). Chromatographic analysis of seed oils. Fatty acid composition of castor oil. J. Am. Oil Chem. Soc.39, 513–7.
9.
9. Kresze, G., Bederke, K., and Schaevffelhut, F. (1965). Analysis of mixtures of mono-and diglycerides by gas chromatography and nuclear magnetic resonance. Z. Anal. Chem.209(2), 329–37.
10.
10. Teupel, M., Pollerberg, J. (1968). Analysis of ricinoleic acid monoglycerides by column chromatoraphy and nuclear magnetic resonance spectroscopy (German abstract). Tenside5(9–10), 275–8.
11.
11. King, J.W., Adams, E.C., and Bidlingmeyer, B.A. (1982). Determination of free fatty acids in natural oils and alkyd resins by high-performance liquid chromatography. J. Liquid Chromatogr.5(2), 275–304.
12.
12. Horwitz, W. (ed.). (1980). Official Methods of Analysis of the Association of Official Analytical Chemists (AOAC), 13th ed.Washington, D.C.: AOAC.
13.
13. Achaya, K.T. (1971). Chemical derivatives of castor oil. J. Am. Oil. Chem. Soc.48(11), 758–63.
14.
14. Rondeau, R. (1968). La lipochimie de l'huile de ricin. Rev. Fr. Corps Gras15(8–9), 529–37.
15.
15. Swern, D. (ed.). (1979). Bailey's Industrial Oil and Fat Products, Vol. 1, 4th ed.New York: John Wiley and Sons.
16.
16. Windholz, M., Budavari, S., Blumetti, R.F., and Otterbein, E.S. (eds.). (1983). The Merck Index, 10th ed.Rahway, NJ: Merck and Co.
18. Ramos, L.C., Tango, J.S., Savi, A., and Leal, N.R. (1984). Variability for oil and fatty acid composition in castor bean varieties. J. Am. Oil Chem. Soc.61(12), 1841–3.
19.
19. FOOD AND DRUG ADMINISTRATION (FDA). (1986). Cosmetic product formulation data table.
20.
20. Eiermann, H.J. (June 12, 1986). Acting Director, Division of Colors and Cosmetics, Food and Drug Administration. Letter to R.L. Elder, of Cosmetic Ingredient Review, on oleic acid group, methylene chloride, and Glyceryl Ricinoleate. Available for review: Director, Cosmetic Ingredient Review, 1110 Vermont Ave., N.W., Suite 810, Washington, D.C. 20005.
21.
21. CODE OF FEDERAL REGULATIONS (CFR). (1984). Title 21. Food and Drugs. Parts 175.105, 176.170, 176.210, 178.3130, 182.90, 182.4505, 720.4.
22.
22. Brown, J.L. (1983). Incomplete labeling of pharmaceuticals: A list of “inactive” ingredients. N. Engl. J. Med.309(7), 439–41.
23.
23. FEDERAL REGISTER. (Sept. 3, 1982). Wart remover drug products for OTC human use; tentative final monograph.47(172), 39103.
24.
24. FEDERAL REGISTER. (May 24, 1972). Certain OTC vaginal contraceptives. Drugs for human use; drug efficacy study implementation.37(101), 10525.
25.
25. Scarpa, A., and Guerci, A. (1982). Various uses of the castor oil plant (Ricinus communis L.). A review. J. Ethnopharmacol.5(2), 117–37.
26.
26. Blacow, N.W. (1972). Martindale. The Extra Pharmacopeia, 26th ed.London: Pharmaceutical Press, p. 1256.
27.
27. FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY (FASEB), Life Sciences Research Office. (1975). Evaluation of the health aspects of glycerin and glycerides as food ingredients. U.S. Department of Commerce. NTIS PB-254536.
28.
28. Watson, W.C., Gordon, R.S., Jr., Karmen, A., and Joyer, A. (1963). The absorption and excretion of castor oil in man. J. Pharm. Pharmacol.15, 183–8.
29.
29. Florkin, M., and Stotz, E.H. (eds.). (1971). Lipid Metabolism, Vol. 18, Comprehensive Biochemistry. New York: Elsevier.
30.
30. Elder, R.L. (ed.). (1982). Final report on the safety assessment of decyl and isodecyl oleates. J. Am. Coll. Toxicol.1(2), 85–95.
31.
31. COSMETIC INGREDIENT REVIEW. (Nov. 13, 1985). Final report on glyceryl oleate. Available for review: Director, Cosmetic Ingredient Review, 1110 Vermont Ave., N.W., Suite 810, Washington, D.C. 20005.
32.
32. Watson, W.C., and Gordon, R.S., Jr. (1962). Studies on the digestion, absorption and metabolism of castor oil. Biochem. Pharmacol.11, 229–36.
33.
33. Rao, M.K.G., Risser, N., and Perkins, E.G. (1969). The incorporation of ricinoleic acid into rat lymph lipids. Proc. Soc. Exp. Biol. Med.131(4), 1369–72.
34.
34. Gaginella, T.S., and Phillips, S.F. (1975). Ricinoleic acid: Current view of an ancient oil. Am. J. Dig. Dis.20(12), 1171–7.
35.
35. Ammon, H.V., Thomas, P.J., and Phillips, S.F. (1974). Effects of oleic and ricinoleic acid on net jejunal water and electrolyte movement. J. Clin. Invest.53, 374–9.
36.
36. Kishimoto, Y., And Radin, N.S. (1963). Occurrence of 2-hydroxy fatty acids in animal tissues. J. Lipid Res.4(2), 139–43.
37.
37. Akanuma, H., and Kishimoto, Y. (1979). Synthesis of ceramides and cerebrosides containing both alpha-hydroxy and non-hydroxy fatty-acids from lignoceroyl-CoA by rat-brain microsomes. J. Biol. Chem.254(4), 1050–6.
38.
38. Stewart, W.C., and Sinclair, R.G. (1945). The absence of ricinoleic acid from phospholipids of rats fed castor oil. Arch. Biochem.89, 7–11.
39.
39. Watson, W.C., and Murray, E.S. (1965). Triricinolein synthesis in vivo. Biochim. Biophys. Acta106(2), 311–4.
40.
40. Barber, E.D., Smith, W.L., and Lands, W.E.M. (1971). Incorporation of ricinoleic acid into glycerolipids. Biochim. Biophys. Acta248(2), 171–9.
41.
41. Hallaba, E., Al-Suhybani, A., Abdullah, M.E., and Zaki, F.S. (1985). Labelling of castor oil for myocardial study. J. Radioanal. Nucl. Chem.89(1), 97–107.
42.
42. Paul, H., and McCay, C.M. (1942). The utilization of fats by herbivora. Arch. Biochem. Biophys.1, 247.
43.
43. Perkins, E.G., Endres, J.C., and Kummerow, F.A. (1961). The metabolism of fats. I. Effect of dietary hydroxy acids and their triglycerides on growth, carcass, and fecal fat composition in the rat. J. Nutr.73, 291.
44.
44. NUTRITION REVIEWS. (1970). Oxidation of unsaturated fatty acids.28(6), 165–67.
45.
45. Morris, L.J. (1970). Mechanisms and stereochemistry in fatty acid metabolism. Biochem. J.118(5), 681–93.
46.
46. Bowen, D.M., and Radin, N.S. (1968). Hydroxy fatty acid metabolism in the brain. Adv. Lipid Res.6, 255–72.
48. Lekakis, N.J. (1977). Alpha-oxidation of fatty acids in Escherichia coli.FEMS Microbiol. Lett.1(5), 289–92.
49.
49. Gunstone, F.D. (1967). An Introduction to the Chemistry and Biochemistry of Fatty Acids and Their Glycerides. Great Britain: Richard Clay (The Chancer Press) Ltd.
50.
50. Uchiyama, M., Sato, R., and Mizugaki, M. (1963). Biochim. Biophys. Acta70, 344–6.
51.
51. Okui, S., Uchiyama, M., Sato, R., and Mizugaki, M. (1964). J. Biochem.55, 81–6.
52.
52. Okui, S., Uchiyama, M., and Mizugaki, M. (1963). J. Biochem.53, 265–70.
53.
53. Mizugaki, M., Fukuyama, H., Sakamoto, T., and Yamanaka, H. (1978). Studies on the metabolism of unsaturated fatty acids I. Synthesis and identification of 6-hydroxydodec-3-cis-enoic acid, the final metabolite of ricinoleic acid by Escherichia coli K-12. Chem. Pharm. Bull.6(8), 2417–21.
54.
54. James, A.T., Webb, J.P.W., and Kellock, T.D. (1961). The occurrence of unusual fatty acids in fecal lipids from human beings with normal and abnormal fat absorption. Biochem. J.78, 333–9.
55.
55. Soong, C.S., Thompson, J.B., Poley, J.R., and Hess, D.R. (1972). Hydroxy fatty acids in human diarrhea. Gastroenterology63, 748–57.
56.
56. Kim, Y.S., and Spritz, N. (1968). Metabolism of hydroxy fatty acids in dogs with steatorrhea secondary to experimentally produced intestinal blind loops. J. Lipid Res.9, 487–91.
57.
57. Thomas, P.J. (1972). Identification of some enteric bacteria which convert oleic acid to hydroxystearic acid in vitro. Gastroenterology62, 430–5.
58.
58. Informatics. (1973). Monograph on glycerine and glycerides. DHEW Contract No. FDA 72–104. NTIS PB-221 227/2.
59.
59. Meyer, H. (1890). Ueber den wirksamen bestandtheil des ricinusols. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol.28, 145–521. (Cited in Ref. 67.)
60.
60. Bright-Asare, P., and Binder, H.J. (1973). Stimulation of colonic secretion of water and electrolytes by hydroxy fatty acids. Gastroenterology64, 81–8.
61.
61. Ammon, H.V., and Phillips, S.F. (1973). Inhibition of colonic water and electrolyte absorption by fatty acids in man. Gastroenterology65, 744–9.
62.
62. Ammon, H.V., and Phillips, S.F. (1974). Inhibition of ileal water absorption by intraluminal fatty acids. J. Clin. Invest.53, 205–10.
63.
63. Stewart, J.J., Gaginella, T.S., Olsen, W.A., and Bass, P. (1975). Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract. J. Pharmacol. Exp. Ther.192, 458–67.
64.
64. Stewart, J.J., Gaginella, T.S., and Bass, P. (1975). Actions of ricinoleic acid and structurally related fatty acids on the gastrointestinal tract. I. Effects on smooth muscle contractility in vitro. J. Pharmacol. Exp. Theor.195(2), 347–54.
65.
65. Gaginella, T.S., Haddad, A.C., Go, V.L., and Phillips, S.F. (1977). Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. J. Pharmacol. Exp. Ther.201(1), 259–66.
66.
66. Gaginella, T.S., and Phillips, S.F. (1976). Ricinoleic acid (castor oil) alters intestinal surface structure. A scanning electron microscopic study. Mayo Clin. Proc.51, 6–12.
67.
67. Gaginella, T.S., Stewart, J.J., Olsen, W.A., and Bass, P. (1975). Actions of ricinoleic acid and structurally related fatty acids on the gastrointestinal tract. II. Effects on water and electrolyte absorption in vitro. J. Pharmacol. Exp. Ther.195(2), 355–61.
68.
68. Cohen, M.M. (1982). The effect of cathartics on prostaglandin synthesis by rat gastrointestinal tract. Prostaglandins Leukotrienes Med.8(4), 389–97.
69.
69. Bretagne, J.F., Vidon, N., L'Hirondel, C., Bernier, J.J., Bovet, M., Maurel, M., Rongier, M., and Rouchette, J. (1981). Increased cell loss in the human jejunum induced by laxatives (ricinoleic acid, dioctyl sodium sulphosuccinate, magnesium sulphate, bile salts). Gut22, 264–9.
70.
70. FEDERAL REGISTER. (March 21, 1975). Proposal to establish monographs for OTC laxative, antidiarrheal, emetic, and antiemetic products.40(56), 12909–10.
71.
71. Pietrusko, R.G. (1977). Use and abuse of laxatives. Am. J. Hosp. Pharm.34(3), 291–300.
72.
72. Dynamit Nobel A.G. (1977). Acute oral toxicity evaluation of Softigen 701 in the mouse. Unpublished data submitted to CTFA.
73.
73. COSMETIC, TOILETRY AND FRAGRANCE ASSOCIATION (CTFA). (1979). Acute oral toxicity of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. 26/63.
74.
74. CTFA. (1979). Acute oral toxicity of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. 26/64.
75.
75. CTFA. (1980). Acute oral toxicity of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. OT29/68.
76.
76. Dynamit Nobel A.G. (1972). Softingen 701: Draize eye test, Draize skin test. Unpublished data submitted to CTFA.
77.
77. Dynamit Nobel A.G. (1980). Primary skin irritation test in the rabbit. Unpublished data submitted to CTFA.
78.
78. CTFA. (1979). Primary skin irritation in rabbits of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. S11/117, product 05C/16813–01.
79.
79. CTFA. (1979). Primary skin irritation in rabbits of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. S11/117, product 05C/16814–01.
80.
80. CTFA. (1979). Primary skin irritation in rabbits of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. S11/117, product 05C/16815–01.
81.
81. CTFA. (1979). Primary skin irritation in rabbits of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. S11/117, product 05C/16816–01.
82.
82. CTFA. (1980). Primary skin irritation in rabbits of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. S12/37.
83.
83. CTFA. (1980). Primary skin irritation in rabbits of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. S12/56.
84.
84. Hem, S.L., Bright, D.R., Banker, G.S., and Pogue, J.P. (1975). Tissue irritation evaluation of potential parenteral vehicles. Drug Dev. Commun.1(5), 471–7.
85.
85. Lorenz, W., Scmal, A., Schult, H., Lang, S., Ohmann, C., Webster, D., Kapp, B., Lueben, L., and Doenicke, A. (1982). Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: Analysis of various components in cremophor EL and development of a compound with reduced toxicity. Agents Actions12, 64–80.
86.
86. Dynamit Nobel A.G. (1980). Primary eye irritation test in the rabbit. Unpublished data submitted to CTFA.
87.
87. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. E43/71.
88.
88. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. 43/70.
89.
89. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. E43/68.
90.
90. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. E43/69.
91.
91. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. E43/229.
92.
92. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. 43/221.
93.
93. CTFA. (1979). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. E46/5.
94.
94. CTFA. (1980). Eye irritation of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. E44/241.
95.
95. NATIONAL TOXICOLOGY PROGRAM (NTP). (April 28, 1986). Telephone inquiry on status of toxicity testing of castor oil by NTP.
96.
96. NTP. (1985). National Toxicology Program: Fiscal Year 1985 Plan. Chemical test results for mutagenicity in Salmonella assays in FY 1984. Washington, D.C.: U.S. Department of Health and Human Services, p. 63.
97.
97. Boyland, E., Roe, F.J.C., and Mitchley, B.C.V. (1966). Test of certain constituents of spermicides for carcinogenicity in genital tract of female mice. Br. J. Cancer20(1), 184–9.
98.
98. CTFA. (1979). Skin irritation potential (human patch test) of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. 4527/4.
99.
99. CTFA. (1980). Skin irritation potential (human patch test) of a product containing Glyceryl Ricinoleate. Washington, D.C. Test no. 4527/46.
100.
100. Ramakrishnan, S., Balasubramanian, K., and Madhavan, M. (1972). Biochemical and pathological studies on castor seed poisoning. J. Assoc. Physicians India20(10), 781–4.
101.
101. El Mahoub, M., Khalifa, M.M., Jaswal, O.B., and Garrah, M.S. (1983). “Ricin syndrome” A possible new teratogenic syndrome associated with ingestion of castor oil seed in early pregnancy: A case report. Ann. Trop. Paediatr.3: 57–61.
102.
102. Lehrer, S.B., Karr, R.M., and Salvaggio, J.E. (1981). Analysis of green coffee bean and castor bean allergens using RAST inhibition. Clin. Allergy11(4), 357–66.
103.
103. Davison, A.G., Britton, M.G., Forrester, J.A., Davies, R.J., and Hughes, D.T.D. (1983). Asthma in merchant seamen and laboratory workers caused by allergy to castor beans (Ricinus communis): Analysis of allergens. Clin. Allergy13(6), 553–62.
104.
104. Kemeny, D.M., Frankland, A.W., Fahkri, Z.I., and Trull, A.K. (1981). Allergy to castor bean in the Sudan: Measurement of serum IgE and specific IgE antibodies. Clin. Allergy11(5), 463–71.
105.
105. Brandle, I., Boujnah-Khouadja, A., and Foussereau, J. (1983). Allergy to castor oil. Contact Dermatitis9(5), 424–5.
106.
106. Sai, S. (1983). Lipstick dermatitis caused by castor oil. Contact Dermatitis9(1), 75.
107.
107. Sai, S. (1983). Lipstick dermatitis caused by ricinoleic acid. Contact Dermatitis9(6), 524.
108.
108. Andersen, K.E., and Nielsen, R. (1984). Lipstick dermatitis related to castor oil. Contact Dermatitis11(4), 253–4.
109.
109. de Darko, E., and Osmundsen, P.E. (1984). Allergic contact dermatitis to Lipcare lipstick. Contact Dermatitis11(1), 46.
